Microbial recognition by Toll-like receptors

Journal of Dermatological Science

Volumn 34, Issue 2, 2004, Pages 73-82

  Takeda, Kiyoshi ^a   Akira, Shizuo ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

Adaptors; Mammalian Toll receptors; TLR; Toll like receptors

Indexed keywords

BETA INTERFERON; CYTOKINE; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR;

BACTERIUM IDENTIFICATION; CYTOPLASM; FUNGUS IDENTIFICATION; HUMAN; IMMUNE SYSTEM; LIGAND BINDING; MICROBIAL IDENTIFICATION; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; VIRUS IDENTIFICATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; ANTIGENS, DIFFERENTIATION; BACTERIAL INFECTIONS; HUMANS; MEMBRANE GLYCOPROTEINS; MYELOID DIFFERENTIATION FACTOR 88; RECEPTORS, CELL SURFACE; RECEPTORS, IMMUNOLOGIC; RECEPTORS, INTERLEUKIN-1; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS;

EID: 1642275486     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2003.10.002     Document Type: Review

References (87)

1. Lemaitre B., Nicolas E., Michaut L., Reichhart J.M., Hoffmann J.A. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell. 86:1996;973-983.
2. Medzhitov R., Preston-Hurlburt P., Janeway C.A. Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature. 388:1997;394-397.
3. Poltorak A., He X., Smirnova I., Liu M.Y., Huffel C.V., Du X.et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutation in Tlr4 gene. Science. 282:1998;2085-2088.
4. Takeda K., Kaisho T., Akira S. Toll-like receptors. Annu. Rev. Immunol. 21:2003;335-376.
5. Beutler B., Rietschel E.T. Innate immune sensing and its roots: the story of endotoxin. Nat. Rev. Immunol. 3:2003;169-176.
6. Watson J., Riblet R. Genetic control of responses to bacterial lipopolysaccharides in mice. I. Evidence for a single gene that influences mitogenic and immunogenic respones to lipopolysaccharides. J. Exp. Med. 140:1974;1147-1161.
7. Hoshino K., Takeuchi O., Kawai T., Sanjo H., Ogawa T., Takeda Y.et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162:1999;3749-3752.
8. Schwadner R., Dziarski R., Wesche H., Rothe M., Kirschning C.J. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by Toll-like receptor 2. J. Biol. Chem. 274:1999;17406-17409.
9. Takeuchi O., Hoshino K., Kawai T., Sanjo H., Takada H., Ogawa T.et al. Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive cell wall components. Immunity. 11:1999;443-451.
10. Yoshimura A., Lien E., Ingalls R.R., Tuomanen E., Dziarski R., Golenbock D.T. Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J. Immunol. 165:1999;1-5.
11. Lehner M.D., Morath S., Michelsen K.S., Schumann R.R., Hartung T. Induction of cross-tolerance by lipopolysaccharide and highly purified lipoteichoic acid via different toll-like receptors independent of paracrine mediators. J. Immunol. 166:2001;5161-5167.
12. Takeuchi O., Hoshino K., Akira S. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J. Immunol. 165:2000;5392-5396.
13. Takeuchi O., Kaufmann A., Grote K., Kawai T., Hoshino K., Morr M.et al. Cutting edge: preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a toll-like receptor 2- and MyD88-dependent signaling pathway. J. Immunol. 164:2000;554-557.
14. Underhill D.M., Ozinsky A., Smith K.D., Aderem A. Toll-like receptor 2 mediates mycobacteria-induced proinflammatory signaling in macrophages. Proc. Natl. Acad. Sci. USA. 96:1999;14459-14463.
15. Means T.K., Wang S., Lien E., Yoshimura A., Golenbock D.T., Fenton M.J. Human Toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J. Immunol. 163:1999;3920-3927.
16. Means T.K., Lien E., Yoshimura A., Wang S., Golenbock D.T., Fenton M.J. The CD14 ligands lipoarabinomannan and lipopolysaccharide differ in their requirement for Toll-like receptors. J. Immunol. 163:1999;6748-6755.
17. Hajjar A.M., O'Mahony D.S., Ozinsky A., Underhill D.M., Aderem A., Klebanoff S.J.et al. Cutting edge: functional interactions between Toll-like receptor (TLR) 2 and TLR1 or TLR6 in response to phenol-soluble modulin. J. Immunol. 166:2001;15-19.
18. Opitz B., Schroder N.W., Spreitzer I., Michelsen K.S., Kirschning C.J., Hallatschek W.et al. Toll-like receptor-2 mediates treponema glycolipid and lipoteichoic acid-induced NF-κB translocation. J. Biol. Chem. 276:2001;22041-22047.
19. Massari P., Henneke P., Ho Y., Latz E., Golenbock D.T., Wetzler L.M. Cutting edge: immune stimulation by Neisserial porins is Toll-like receptor 2 and MyD88 dependent. J. Immunol. 168:2002;1533-1537.
20. Ozinsky A., Underhill D.M., Fontenot J.D., Hajjar A.M., Smith K.D., Wilson C.B.et al. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors. Proc. Natl. Acad. Sci. USA. 97:2000;13766-13771.
21. Takeuchi O., Kawai T., Muhlradt P.F., Radolf J.D., Zychlinsky A., Takeda K.et al. Discrimination of bacterial lipopeptides by Toll-like receptor 6. Int. Immunol. 13:2001;933-940.
22. Takeuchi O., Horiuchi T., Hoshino K., Takeda K., Dong Z., Modlin R.L.et al. Role of TLR1 in mediating immune response to microbial lipoproteins. J. Immunol. 169:2002;10-14.
23. Hayashi F., Smith K.D., Ozinsky A., Hawn T.R., Yi E.C., Goodlett D.R.et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor-5. Nature. 410:2001;1099-1103.
24. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H.et al. A Toll-like receptor recognizes bacterial DNA. Nature. 408:2000;740-745.
25. Underhill D.M., Ozinsky A., Hajjar A.M., Stevens A., Wilson C.B., Bassetti M.et al. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature. 401:1999;811-815.
26. Kataoka K., Muta T., Yamazaki S., Takeshige K. Activation of macrophages by linear (1-3)-β-D-glucans. Implications for the recognition of fungi by innate immunity. J. Biol. Chem. 277:2002;36825-36831.
27. Campos M.A., Almeida I.C., Takeuchi O., Akira S., Valente E.P., Procopio D.O.et al. Activation of Toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite. J. Immunol. 167:2001;416-423.
28. Ropert C., Ferreira L.R., Campos M.A., Procopio D.O., Travassos L.R., Ferguson M.A.et al. Macrophage signaling by glycosylphosphatidylinositol- anchored mucin-like glycoproteins derived from Trypanosoma cruzi trypomastigotes. Microbes Infect. 4:2002;1015-1025.
29. Hawn T.R., Ozinsky A., Underhill D.M., Buckner F.S., Akira S., Aderem A. Leishmania major activates IL-1α expression in macrophages through a MyD88-dependent pathway. Microbes Infect. 4:2002;763-771.
30. Scanga C.A., Aliberti J., Jankovic D., Tilloy F., Bennouna S., Denkers E.Y.et al. Cutting edge: MyD88 is required for resistance to Toxoplasma gondii infection and regulates parasite-induced IL-12 production by dendritic cells. J. Immunol. 168:2002;5997-6001.
31. Bowie A., Kiss-Toth E., Symons J.A., Smith G.L., Dower S.K., O'Neill L.A. A46R and A52R from vaccinia virus are antagonists of host IL-1 and Toll-like receptor signaling. Proc. Natl. Acad. Sci. U.S.A. 97:2000;10162-10167.
32. Harte M.T., Haga I.R., Maloney G., Gray P., Reading P.C., Bartlett N.W. et al. The poxvirus protein A52R targets Toll-like receptor signaling complexes to suppress host defense. J. Exp. Med. 197:2003;343-351.
33. Kurt-Jones E.A., Popova L., Kwinn L., Haynes L.M., Jones L.P., Tripp R.A.et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat. Immunol. 1:2000;398-401.
34. Haynes L.M., Moore D.D., Kurt-Jones E.A., Finberg R.W., Anderson L.J., Tripp R.A. Involvement of Toll-like receptor 4 in innate immunity to respiratory syncytial virus. J. Virol. 75:2001;10730-10737.
35. Rassa J.C., Meyers J.L., Zhang Y., Kudaravalli R., Ross S.R. Murine retroviruses activate B cells via interaction with Toll-like receptor 4. Proc. Natl. Acad. Sci. USA. 99:2002;2281-2286.
36. Alexopoulou L., Holt A.C., Medzhitov R., Flavell R.A. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature. 413:2001;732-738.
37. Matsumoto M., Kikkawa S., Kohase M., Miyake K., Seya T. Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling. Biochem. Biophys. Res. Commun. 293:2002;1364-1369.
38. Hemmi H., Kaisho T., Takeuchi O., Sato S., Sanjo H., Hoshino K.et al. Small anti-viral compounds activate immune cells via the TLR7-MyD88-dependent signaling pathway. Nat. Immunol. 3:2002;196-200.
39. Hemmi H., Kaisho T., Takeda K., Akira S. The roles of Toll-like receptor 9, MyD88, and DNA-PKcs in the effects of two distinct CpG DNAs on dendritic cell subsets. J. Immunol. 170:2003;3059-3064.
40. Lund J., Sato A., Akira S., Medzhitov R., Iwasaki A. Toll-like receptor 9-mediated recognition of herpes simplex virus-2 by plasmacytoid dendritic cells. J. Exp. Med. 198:2003;513-520.
41. Okamura Y., Watari M., Jerud E.S., Young D.W., Ishizaka S.T., Rose J.et al. The extra domain A of fibronectin activates Toll-like receptor 4. J. Biol. Chem. 276:2001;10229-10233.
42. Termeer C., Benedix F., Sleeman J., Fieber C., Voith U., Ahrens T.et al. Oligosaccharides of hyaluronan activate dendritic cells via Toll-like receptor 4. J. Exp. Med. 195:2002;99-111.
43. Johnson G.B., Brunn G.J., Kodaira Y., Platt J.L. Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. J. Immunol. 168:2002;5233-5239.
44. Ohashi K., Burkart V., Flohe S., Kolb H. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J. Immunol. 164:2000;558-561.
45. Vabulas R.M., Ahmad-Nejad P., da Costa C., Miethke T., Kirschning C.J., Hacker H.et al. Endocytosed HSP60s use toll-like receptor 2 (TLR2) and TLR4 to activate the toll/interleukin-1 receptor signaling pathway in innate immune cells. J. Biol. Chem. 276:2001;31332-31339.
46. Vabulas R.M., Ahmad-Nejad P., Ghose S., Kirschning C.J., Issels R.D., Wagner H. HSP70 as endogenous stimulus of toll/interleukin-1 receptor signal pathway. J. Biol. Chem. 277:2002;15107-15112.
47. Asea A., Rehli M., Kabingu E., Boch J.A., Bare O., Auron P.E.et al. Novel signal transduction pathway utilized by extracellular HSP70: role of TLR2 and TLR4. J. Biol. Chem. 277:2002;15028-15034.
48. Smiley S.T., King J.A., Hancock W.W. Fibrinogen stimulates macrophage chemokine secretion through Toll-like receptor 4. J. Immunol. 167:2001;2887-2894.
49. Gao B., Tsan M.F. Endotoxin contamination in recombinant human Hsp70 preparation is responsible for the induction of TNFα release by murine macrophages. J. Biol. Chem. 278:2003;174-179.
50. Akira S., Takeda K., Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2:2001;675-680.
51. Li S., Strelow A., Fontana E.J., Wesche H. IRAK-4 - a novel member of the IRAK family with the properties of an IRAK-kinase. Proc. Natl. Acad. Sci. USA. 99:2002;5567-5572.
52. Suzuki N., Suzuki S., Duncan G.S., Millar D.G., Wada T., Mirtsos C.et al. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. Nature. 416:2002;750-756.
53. Kanakaraj P., Ngo K., Wu Y., Angulo A., Ghazal P., Harris C.A.et al. Defective interleukin (IL)-18-mediated natural killer and T helper cell type 1 responses in IL-1 receptor-associated kinase (IRAK)-deficient mice. J. Exp. Med. 187:1998;2073-2079.
54. Thomas J.A., Allen J.L., Tsen M., Dubnicoff T., Danao J., Liao X.C.et al. Impaired cytokine signaling in mice lacking the IL-1 receptor-associated kinase. J. Immunol. 163:1999;978-984.
55. Swantek J.L., Tsen M.F., Cobb M.H., Thomas J.A. IL-1 receptor-associated kinase modulates host responsiveness to endotoxin. J. Immunol. 164:2000;4301-4306.
56. Picard C., Puel A., Bonnet M., Ku C.L., Bustamante J., Yang K.et al. Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science. 299:2003;2076-2079.
57. Kobayashi K., Hernandez L.D., Galan J.E., Janeway C.A. Jr., Medzhitov R., Flavell R.A. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell. 110:2002;191-202.
58. Lomaga M.A., Yeh W.C., Sarosi I., Duncan G.S., Furlonger C., Ho A.et al. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev. 13:1999;1015-1024.
59. Naito A., Azuma S., Tanaka S., Miyazaki T., Takaki S., Takatsu K.et al. Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice. Genes Cells. 4:1999;353-362.
60. Takeda K., Takeuchi O., Tsujimura T., Itami S., Adachi O., Kawai T.et al. Limb and skin abnormalities in mice lacking IKKα Science. 284:1999;313-316.
61. Chu W.M., Ostertag D., Li Z.W., Chang L., Chen Y., Hu Y.et al. JNK2 and IKKβ are required for activating the innate response to viral infection. Immunity. 11:1999;721-731.
62. Rudolph D., Yeh W.C., Wakeham A., Rudolph B., Nallainathan D., Potter J.et al. Severe liver degeneration and lack of NF-κB activation in NEMO/IKKγ-deficient mice. Genes Dev. 14:2000;854-862.
63. Kawai T., Adachi O., Ogawa T., Takeda K., Akira S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity. 11:1999;115-122.
64. Kawai T., Takeuchi O., Fujita T., Inoue J., Muhlradt P.F., Sato S.et al. Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IRF-3 and the expression of a subset of LPS-inducible genes. J. Immunol. 167:2001;5887-5894.
65. Sakaguchi S., Negishi H., Asagiri M., Nakajima C., Mizutani T., Takaoka A.et al. Essential role of IRF-3 in lipopolysaccharide-induced interferon-β gene expression and endotoxin shock. Biochem. Biophys. Res. Commun. 306:2003;860-866.
66. Toshchakov V., Jones B.W., Perera P.Y., Thomas K., Cody M.J., Zhang S.et al. TLR4, but not TLR2, mediates IFN-β-induced STAT1α/β- dependent gene expression in macrophages. Nat. Immunol. 3:2002;392-398.
67. Hoshino K., Kaisho T., Iwabe T., Takeuchi O., Akira S. Differential involvement of IFN- in Toll-like receptor-stimulated dendritic cell activation. Int. Immunol. 14:2002;1225-1231.
68. Doyle S.E., Vaidya S.A., O'Connell R., Dadgostar H., Dempsey P.W., Wu T.T.et al. IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity. 17:2002;251-263.
69. Weaver B.K., Kumar K.P., Reich N.C. Interferon regulatory factor 3 and CREB-binding protein/p300 are subunits of double-stranded RNA-activated transcription factor DRAF1. Mol. Cell. Biol. 18:1998;1359-1368.
70. Yoneyama M., Suhara W., Fukuhara Y., Fukuda M., Nishida E., Fujita T. Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300. EMBO J. 17:1998;1087-1095.
71. Sharma S., tenOever B.R., Grandvaux N., Zhou G.P., Lin R., Hiscott J. Triggering the interferon antiviral response through an IKK-related pathway. Science. 300:2003;1148-1151.
72. Fitzgerald K.A., McWhirter S.M., Faia K.L., Rowe D.C., Latz E., Golenbock D.T.et al. IKKε and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4:2003;491-496.
73. Shimada T., Kawai T., Takeda K., Matsumoto M., Inoue J., Tatsumi Y.et al. IKK-i, a novel lipopolysaccharide-inducible kinase that is related to IκB kinases. Int. Immunol. 11:1999;1357-1362.
74. Pomerantz J.L., Baltimore D. NF-κB activation by a signaling complex containing TRAF2 TANK and TBK1, a novel IKK-related kinase. EMBO J. 18:1999;6694-6704.
75. Peters R.T., Liao S.M., Maniatis T. IKKε is part of a novel PMA-inducible IκB kinase complex. Mol. Cell. 5:2000;513-522.
76. Nomura F., Kawai T., Nakanishi K., Akira S. NF-κB activation through IKK-i-dependent I-TRAF/TANK phosphorylation. Genes Cells. 5:2000;191-202.
77. Horng T., Barton G.M., Medzhitov R. TIRAP: an adapter molecule in the Toll signaling pathway. Nat. Immunol. 2:2001;835-841.
78. Fitzgerald K.A., Palsson-McDermott E.M., Bowie A.G., Jefferies C., Mansell A.S., Brady G.et al. Mal (MyD88-adaptor-like) is required for Toll-like receptor-4 signal transduction. Nature. 413:2001;78-83.
79. Yamamoto M., Sato S., Hemmi H., Sanjo H., Uematsu S., Kaisho T.et al. Essential role of TIRAP/Mal for activation of the signaling cascade shared by TLR2 and TLR4. Nature. 420:2002;324-329.
80. Horng T., Barton G.M., Flavell R.A., Medzhitov R. The adaptor molecule TIRAP provides signaling specificity for Toll-like receptors. Nature. 420:2002;329-333.
81. Yamamoto M., Sato S., Mori K., Takeuchi O., Hoshino K., Takeda K.et al. A novel TIR domain-containing adaptor that preferentially activates the interferon-β promoter. J. Immunol. 169:2002;6668-6672.
82. Oshiumi H., Matsumoto M., Funami K., Akazawa T., Seya T. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-β induction. Nat. Immunol. 4:2003;161-167.
83. Yamamoto M., Sato S., Hemmi H., Hoshino K., Kaisho T., Sanjo H.et al. Role of adaptor TRIF in the MyD88-independent Toll-like receptor signaling pathway. Science. 301:2003;640-643.
84. Hoebe K., Du X., Georgel P., Janssen E., Tabeta K., Kim S.O.et al. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature. 424:2003;743-748.
85. Bin L.H., Xu L.G., Shu H.B. TIRP: a novel TIR domain-containing adapter protein involved in Toll/interleukin-1 receptor signaling. J. Biol. Chem. 278:2003;24526-24532.
86. Yamamoto M., Sato S., Hemmi H., Uematsu S., Hoshino K., Kaisho T.et al. TRAM is specifically involved in the TLR4-mediated MyD88-independent signaling pathway. Nat Immunol. 4:2003;1140-1150.
87. O'Neill L.A., Fitzgerald K.A., Bowie A.G. The Toll-IL-1 receptor adaptor family grows to five members. Trends Immunol. 24:2003;286-290.